<?xml version="1.0" encoding="ISO-8859-1"?>

<?xml-stylesheet type="text/css" href="https://www.webwire.com/includes/rssstyle.css"?>

<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
  
  <!-- Issuers of news/press releases and NOT WebWire are solely responsible for the accuracy of the content. -->



    <title>WebWire | News by Industry : Medical / Pharmaceuticals</title>
    <link>https://www.webwire.com/</link>
    <description>Medical / Pharmaceuticals News by WebWire</description>
    <language>en-US</language>
    <copyright>Copyright &#169; 2026 WebWire. All Rights Reserved.</copyright>
    <ttl>15</ttl>
    <lastBuildDate>Mon, 11 May 2026 20:58:34 EDT</lastBuildDate>
	<image>
      <title>WebWire | News by Industry : Medical / Pharmaceuticals</title>
      <width>140</width>
      <height>32</height>
      <link>https://www.webwire.com/</link>
      <url>https://www.webwire.com/imgs/webwire_logo_140x32.gif</url>
    </image>
	

  <item>
     <title>New Book Empowers Seniors to Harness the Benefits of Cannabis for Health and Well-Being</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354534</link>
     <pubDate>Mon, 11 May 2026 18:11:00 EDT</pubDate>
     <description><![CDATA[<p>Seniors seeking natural alternatives to improve their health and quality of life now have a comprehensive guide to turn to. Renowned author and counseling psychologist  Beverly A. Potter, PhD, has released her latest book,   &#8220;Cannabis for Seniors,&#8221;   a resource designed to educate seniors, their families, and caregivers about the potential benefits of cannabis use. -   -  This insightful book explores the latest research on cann</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354534">https://www.webwire.com/ViewPressRel.asp?aId=354534</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/82679/354534/354534-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354534</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Nutrition and Body Image Program Supports Healthier Behaviors in Women Undergoing Substance Use Treatment</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354444</link>
     <pubDate>Fri, 8 May 2026 10:46:24 EDT</pubDate>
     <description><![CDATA[<p> A  recent study  in the   Journal of Nutrition Education and Behavior   (JNEB), published by Elsevier, examined the impact of the Healthy Steps to Freedom (HSF-10) program on nutrition, body image, and health-related behaviors among 607 women undergoing treatment for substance use. Findings demonstrated that participation in the 10-week intervention program was associated with significant improvements in nutrition behaviors, physical activity, and intuitive eating, alongside reductions in...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354444">https://www.webwire.com/ViewPressRel.asp?aId=354444</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/354444/354444-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354444</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>New evidence confirms malaria vaccine saves child lives and will have high impact in wider rollout</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354436</link>
     <pubDate>Fri, 8 May 2026 10:21:14 EDT</pubDate>
     <description><![CDATA[<p> Findings of a rigorous evaluation of the public health use of the RTS, S malaria vaccine, published today in  The Lancet, confirm significant reduction in child deaths in the first African countries to offer the vaccine.  -   -  Over a period of four years, an estimated 1 in 8 child deaths were averted among those eligible to receive the malaria vaccine in Ghana, Kenya and Malawi. According to the authors, positive impact is likely to be as high or higher in other African countries now offerin...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354436">https://www.webwire.com/ViewPressRel.asp?aId=354436</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/354436/354436-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354436</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>&#8220;Musings on Medicine, Myth, and History: India&#39;s Legacy,&#8221; Best-Selling Book Free for One More Day (Ending Soon) (Until 5/8/2026)</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354115</link>
     <pubDate>Fri, 8 May 2026 06:00:00 EDT</pubDate>
     <description><![CDATA[<p> Best Seller Publishing announces the release of VK Raju and Leela Raju&#39;s new book,   &#8220;Musings on Medicine, Myth, and History: India&#39;s Legacy.&#8221;   The book is currently free and available for download on Amazon for one more day. -   -   &#8220;Musings on Medicine, Myth, and History: India&#39;s Legacy&#8221;  is about a collection of essays by V. K. Raju and Leela Raju that explores ancient medical traditions and India&#39;s contributions to healthcare, particularly in ophthalmology. The authors present a holistic...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354115">https://www.webwire.com/ViewPressRel.asp?aId=354115</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/40662/354115/354115-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354115</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Elsevier&#39;s ClinicalPath is now a Recognized Quality Solution for the ASCO Certified Program</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354347</link>
     <pubDate>Thu, 7 May 2026 09:07:35 EDT</pubDate>
     <description><![CDATA[<p> Elsevier today announced that ClinicalPath, its oncology decision support solution, has been designated a Recognized Quality Solution (RQS) by the Association for Clinical Oncology for the  ASCO Certified  program, reinforcing its role in advancing high-quality, patient-centered cancer care. -   -  Omry Bigger, President, Clinical Solutions, Elsevier said &#8220;Cancer practices want to deliver the best care possible, and this recognition means they can be even more confident in the value ClinicalPa...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354347">https://www.webwire.com/ViewPressRel.asp?aId=354347</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/354347/354347-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354347</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Wisdom Ventures Closes Oversubscribed $77.7M Fund II to Advance Tech Enabled Wellbeing</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354310</link>
     <pubDate>Thu, 7 May 2026 09:02:08 EDT</pubDate>
     <description><![CDATA[<p>  Wisdom Ventures, a leading early stage VC fund investing in tech-enabled wellbeing, today announced the close of its oversubscribed $77.7M Fund II. The new raise comes after the successful deployment of its $10 million Fund I. With the new fundraise, Wisdom Ventures will deepen its investment in startups building technologies that advance human resilience and wellbeing at scale. -   -  &#8220;In an era where AI is reshaping every facet of our lives, Wisdom Ventures&#39; mission of ensuring humanity&#39;s w...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354310">https://www.webwire.com/ViewPressRel.asp?aId=354310</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/81468/354310/354310-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354310</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>&#8220;Musings on Medicine, Myth, and History: India&#39;s Legacy,&#8221; Best-Selling Book Offered for Free (Ending Soon) (Until 5/8/2026)</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354114</link>
     <pubDate>Wed, 6 May 2026 06:00:00 EDT</pubDate>
     <description><![CDATA[<p> Best Seller Publishing announces the release of VK Raju and Leela Raju&#39;s new book,   &#8220;Musings on Medicine, Myth, and History: India&#39;s Legacy.&#8221;   It will be available in the Amazon store for free for two more days. -   -   &#8220;Musings on Medicine, Myth, and History: India&#39;s Legacy&#8221;  is about a collection of essays by V. K. Raju and Leela Raju that explores ancient medical traditions and India&#39;s contributions to healthcare, particularly in ophthalmology. The authors present a holistic view of early...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354114">https://www.webwire.com/ViewPressRel.asp?aId=354114</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/40662/354114/354114-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354114</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>ConV2X 2026 Decentralized Health Summit Returns to Cambridge, MA, Convening Global Leaders Across Healthcare, Life Sciences, Policy, Research, and Technology</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354233</link>
     <pubDate>Tue, 5 May 2026 08:30:00 EDT</pubDate>
     <description><![CDATA[<p> ConV2X has announced the 2026 Decentralized Health Summit, a premier in person gathering bringing together leaders from healthcare delivery, life sciences, research, policy, investment, and technology to explore and accelerate the next era of decentralized health. -   -  Scheduled for  September 24&#8211;25, 2026, in Cambridge, Massachusetts, the Summit convenes a cross-disciplinary community including healthcare executives, academic and industry researchers, pharmaceutical and biotech leaders, poli...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354233">https://www.webwire.com/ViewPressRel.asp?aId=354233</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/354233/354233-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354233</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>New BHTY Issue Spotlights Safe AI, Clinical Data Systems, Blockchain Infrastructure, and Pharma Innovation</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354194</link>
     <pubDate>Mon, 4 May 2026 08:30:00 EDT</pubDate>
     <description><![CDATA[<p>   Blockchain in Healthcare Today (BHTY)   has released its latest issue, delivering a multidisciplinary collection of peer reviewed research, publisher insight, and executive thought leadership advancing the global conversation on decentralized healthcare, safe AI, blockchain enabled infrastructure, and pharmaceutical innovation. -   -  This new edition reinforces BHTY&#39;s role as a leading scholarly and industry resource at the convergence of healthcare transformation and emerging technologies....</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354194">https://www.webwire.com/ViewPressRel.asp?aId=354194</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/354194/354194-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354194</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>&#8220;Musings on Medicine, Myth, and History: India&#39;s Legacy&#8221; is Free to Download for Only Five Days (Until 5/8/2026)</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354113</link>
     <pubDate>Mon, 4 May 2026 06:00:00 EDT</pubDate>
     <description><![CDATA[<p> Best Seller Publishing announces the release of VK Raju and Leela Raju&#39;s new book,   &#8220;Musings on Medicine, Myth, and History: India&#39;s Legacy.&#8221;   It will be available in the Amazon store for free for only five days. -   -   &#8220;Musings on Medicine, Myth, and History: India&#39;s Legacy&#8221;  is about a collection of essays by V. K. Raju and Leela Raju that explores ancient medical traditions and India&#39;s contributions to healthcare, particularly in ophthalmology. The authors present a holistic view of earl...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354113">https://www.webwire.com/ViewPressRel.asp?aId=354113</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/40662/354113/354113-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354113</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>AMA urges physician protections against AI deepfake impersonation</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354107</link>
     <pubDate>Thu, 30 Apr 2026 10:11:23 EDT</pubDate>
     <description><![CDATA[<p> Responding to the escalating risk of AI-manipulated images, videos and audio that impersonate physicians, the American Medical Association (AMA) today announced a new comprehensive  policy framework  to establish clear, enforceable protections for physicians against unauthorized AI-generated &#8220;deepfakes.&#8221; -   -  Created by the  AMA Center for Digital Health and AI, the framework is designed to modernize physician identity protections and close legal gaps to uphold patient safety, professional i...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354107">https://www.webwire.com/ViewPressRel.asp?aId=354107</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/354107/354107-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354107</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Study: Immigrants help address the US eldercare shortage</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354105</link>
     <pubDate>Thu, 30 Apr 2026 10:06:21 EDT</pubDate>
     <description><![CDATA[<p> Good caregivers are often in short supply, but after the Covid-19 pandemic hit the U.S. in early 2020, staff levels at nursing homes dropped by 10 percent. What was a simple personnel shortage has moved closer to being a nursing-care crisis. -   -  &#8220;We have an aging population, care for them is labor-intensive, and there are shortages everywhere in that supply chain,&#8221; says MIT economist Jonathan Gruber. -   -  As it happens, about one-fifth of health care support workers in the U.S. are immigrants...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354105">https://www.webwire.com/ViewPressRel.asp?aId=354105</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/354105/354105-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354105</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Annual General Meeting of April 29, 2026 - Bel�n Garijo appointed as Director and Chief Executive Officer of Sanofi</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354073</link>
     <pubDate>Wed, 29 Apr 2026 13:33:28 EDT</pubDate>
     <description><![CDATA[<p> Sanofi&#39;s Mixed General Meeting of Shareholders convened on April 29, 2026, under the chairmanship of Fr�d�ric Oud�a. -   -   All resolutions were approved with a high level of shareholder support, in particular the appointment of Bel�n Garijo as a board member. In line with the Board&#39;s decision of February 11, Bel�n Garijo will assume her duties as Chief Executive Officer on May 1, 2026. -   -    Fr�d�ric Oud�a,    Chairman of the Board of Directors ,    stated:   &#8220;Bel�n Garijo possesses a rare c...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354073">https://www.webwire.com/ViewPressRel.asp?aId=354073</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/8/354073/354073-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354073</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Johnson &amp; Johnson to Participate in the Bernstein&#39;s 42nd Annual Strategic Decisions Conference</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354018</link>
     <pubDate>Tue, 28 Apr 2026 11:48:30 EDT</pubDate>
     <description><![CDATA[<p> Johnson &amp; Johnson (NYSE: JNJ) will present at the Bernstein&#39;s 42 nd  Annual Strategic Decisions Conference on Wednesday, May 27 th, 2026. Management will participate in a Fireside Chat at 11:00 a.m. Eastern Time. -   -  A live audio webcast of the presentation will be accessible through Johnson &amp; Johnson&#39;s Investor Relations website at  www.investor.jnj.com. An archived edition of the session will be available later that day. -   -  The audio webcast replay will be available approximately 48 hours...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354018">https://www.webwire.com/ViewPressRel.asp?aId=354018</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/354018/354018-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354018</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Novel Study Maps Changes in US Immigration Policy Landscape Since 9/11</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354010</link>
     <pubDate>Tue, 28 Apr 2026 11:26:15 EDT</pubDate>
     <description><![CDATA[<p> In a comprehensive analysis of state and local sanctuary and anti-sanctuary policies, researchers have mapped the rapidly evolving legal immigration landscape in the US from 2000 to 2021. The dataset sheds light on trends in immigration legislation including &#8220;punitive&#8221; preemption, state government tendencies to enact laws that are ideologically opposed to the current federal administration, and conservative states using preemption to control liberal localities. The findings of the  study ...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354010">https://www.webwire.com/ViewPressRel.asp?aId=354010</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/354010/354010-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354010</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>&#8220;Bride and Blades&#8221; Shows How Marriage and Medicine Can Thrive Together</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=350467</link>
     <pubDate>Mon, 27 Apr 2026 21:11:38 EDT</pubDate>
     <description><![CDATA[<p> Dr. Albert H. Yurvati, DO, PhD, DSc(hc), FACOS, FAHA, introduces his compelling new release,  &#8220;Bride and Blades: How to Survive a Surgical Marriage.&#8221;  Part memoir, part manual, the book explores how couples can endure the rigorous demands of medical careers while sustaining love and commitment. -   -  The work unfolds through the stages of marriage: before medical training, during schooling, in residency, and beyond, addressing stress, financial struggles, and health challenges. Yurvati&#39;s stor...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=350467">https://www.webwire.com/ViewPressRel.asp?aId=350467</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/86667/350467/350467-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID350467</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Sanofi successfully prices 2.3 billion of bond issue</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353969</link>
     <pubDate>Mon, 27 Apr 2026 18:35:18 EDT</pubDate>
     <description><![CDATA[<p> Sanofi announces that it has successfully priced its offering of &#8364;2.3 billion of notes across 3 tranches:  -   -    -  &#8226; &#8364;1,000 million fixed-rate notes, due May 2029, bearing interest at an annual rate of 3.000%  -  &#8226; &#8364;650 million fixed-rate notes, due May 2033, bearing interest at an annual rate of 3.375%  -  &#8226; &#8364;650 million fixed-rate notes, due May 2037, bearing interest at an annual rate of 3.750%  -   -    -   -   The notes are being issued under Sanofi&#39;s Euro Medium Term Note programme.   -   -  Sanofi in...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353969">https://www.webwire.com/ViewPressRel.asp?aId=353969</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/8/353969/353969-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353969</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Blockchain in Healthcare Today Reaches H-Index 12 Expanding PubMed Indexed Digital Health Research Impact</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353921</link>
     <pubDate>Mon, 27 Apr 2026 08:00:00 EDT</pubDate>
     <description><![CDATA[<p>  Blockchain in Healthcare Today (BHTY), a peer-reviewed open access journal focused on blockchain and decentralized technologies in healthcare and life sciences, has reached an  H-index of 12, according to SCImago SJR 2025 data. -   -  This milestone indicates that  12 BHTY articles have each received at least 12 independent citations, reflecting sustained engagement from the global research community. -   -  Launched in 2018, BHTY was the first journal dedicated exclusively to blockchain applicat...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353921">https://www.webwire.com/ViewPressRel.asp?aId=353921</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/353921/353921-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353921</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Dr. Albert H. Yurvati Offers an Honest Insight into Life in a Surgical Marriage</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353867</link>
     <pubDate>Thu, 23 Apr 2026 21:57:21 EDT</pubDate>
     <description><![CDATA[<p> Author Dr. Albert H. Yurvati, DO, PhD, DSc(hc), FAHA, DFACOS, brings readers a unique blend of memoir and practical advice in &#8220;Bride and Blades: How to Survive a Surgical Marriage.&#8221; His story spans decades of surgical practice alongside a marriage of over 50 years, offering wisdom to couples navigating the pressures of medicine. -   -  The book examines life stages from marrying before, during, or after medical training, and handling major life changes later on. With candid anecdotes, Yurvati...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353867">https://www.webwire.com/ViewPressRel.asp?aId=353867</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/86667/353867/353867-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353867</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Sanofi and Regeneron&#39;s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353853</link>
     <pubDate>Thu, 23 Apr 2026 11:08:24 EDT</pubDate>
     <description><![CDATA[<p> -    -  &#8226; Approval for children aged two to 11 years with CSU who remain symptomatic despite H1 antihistamine treatment based primarily on data from the LIBERTY-CUPID clinical study program -  &#8226; CSU is a chronic skin disease that causes itch and hives that can be debilitating for young children, especially for those whose disease remains uncontrolled -  &#8226; CSU marks the fifth disease driven in part by type 2 inflammation for which Dupixent is approved in children younger than 12 years of age -   -    -  ...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353853">https://www.webwire.com/ViewPressRel.asp?aId=353853</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/8/353853/353853-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353853</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>How do patients&#39; relatives and friends view the benefits and harms of electroconvulsive therapy?</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353838</link>
     <pubDate>Thu, 23 Apr 2026 10:07:34 EDT</pubDate>
     <description><![CDATA[<p> Electroconvulsive therapy (ECT), which involves passing electricity through the brain under general anesthesia to cause a seizure, usually between six and twelve times, is used to varying degrees around the world for patients with depression and other mental conditions. A study in   Psychology and Psychotherapy: Theory, Research and Practice   reveals that the experiences of families and friends of individuals undergoing ECT challenge claims that the therapy is safe and effective. -   -  In th...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353838">https://www.webwire.com/ViewPressRel.asp?aId=353838</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/353838/353838-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353838</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>AMA urges Congress to strengthen safeguards for AI chatbots</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353798</link>
     <pubDate>Wed, 22 Apr 2026 12:15:34 EDT</pubDate>
     <description><![CDATA[<p> The American Medical Association (AMA) today urged federal lawmakers to put stronger safeguards in place as the use of augmented intelligence (AI) chatbots in mental health care continues to grow. The AMA emphasized both the promise and risks of these rapidly expanding technologies. -   -  In letters to the co-chairs of the  Congressional Artificial Intelligence Caucus  (PDF), the  Congressional Digital Health Caucus  (PDF), and the  Senate Artificial Intelligence Caucus  (PDF), the AMA recogn...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353798">https://www.webwire.com/ViewPressRel.asp?aId=353798</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/353798/353798-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353798</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Sanofi&#39;s Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353786</link>
     <pubDate>Wed, 22 Apr 2026 11:18:17 EDT</pubDate>
     <description><![CDATA[<p> -    -  &#8226; Expanded approval includes children aged one year and above with stage 2 T1D to delay the onset of stage 3 -  &#8226; Tzield is the first disease-modifying therapy for children aged one year and above diagnosed with stage 2 T1D -    -   -   The US Food and Drug Administration (FDA) has approved the supplemental biologic license application for Tzield (teplizumab-mzwv), expanding the indication from eight years and older to as young as one year of age to delay the onset of stage 3 type 1 diabetes (...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353786">https://www.webwire.com/ViewPressRel.asp?aId=353786</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/8/353786/353786-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353786</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>AMA: Physician burnout rates are falling, specialty gaps remain</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353645</link>
     <pubDate>Mon, 20 Apr 2026 11:06:30 EDT</pubDate>
     <description><![CDATA[<p> New data from the American Medical Association (AMA) show physician burnout continuing to decline nationwide, but significant differences across medical specialties underscore the need for more targeted solutions within health systems. -   -  In 2025, 41.9% of physicians reported experiencing at least one symptom of burnout&#8212;down from 43.2% in 2024 and 48.2% in 2023&#8212;reflecting steady progress in physician well-being also found in  peer-reviewed research. However, AMA-exclusive data reveal that...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353645">https://www.webwire.com/ViewPressRel.asp?aId=353645</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/353645/353645-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353645</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Telehealth and Medicine Today Achieves Q2 SCImago Ranking Advancing Its Global Research Presence</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353618</link>
     <pubDate>Mon, 20 Apr 2026 08:00:00 EDT</pubDate>
     <description><![CDATA[<p> Telehealth and Medicine Today (THMT), the peer-reviewed open access journal published by Partners in Digital Health, has achieved a Q2 quartile ranking in SCImago Journal Rank 2025&#8212;placing it in the top half of journals globally and reflecting the journal&#39;s growing interdisciplinary reach and the quality of research it has published since its founding. -   -  A  Scopus-indexed, interdisciplinary telehealth journal with an affordable APC and growing global citation impact, THMT continues to exp...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353618">https://www.webwire.com/ViewPressRel.asp?aId=353618</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/353618/353618-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353618</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Novel Research Reveals the Active Role that Skin Cells Play in Rabies Infection</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353535</link>
     <pubDate>Fri, 17 Apr 2026 12:21:02 EDT</pubDate>
     <description><![CDATA[<p> While it was previously thought that keratinocytes (skin cells) were only passive conductors that allow the rabies virus to pass through, novel research reveals that these cells play a much more active role. The findings of a  new study  in the   Journal of Investigative Dermatology   ( JID ), published by Elsevier, provide direct evidence that keratinocytes can support viral replication and transmit the rabies virus to neurons. The investigators offer a mechanistic explanation for how sup...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353535">https://www.webwire.com/ViewPressRel.asp?aId=353535</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/353535/353535-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353535</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Osteoboost Secures $8M to Expand Access to its FDA-Cleared Prescription Wearable for Bone Health</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353314</link>
     <pubDate>Wed, 15 Apr 2026 12:00:00 EDT</pubDate>
     <description><![CDATA[<p>  Osteoboost Health, Inc., today announced it has closed an $8 million financing round to scale manufacturing, expand clinical research, and broaden the commercial reach of the company&#39;s FDA-cleared medical device for low bone density. The round was led by Ambit Health Ventures, with participation from new investors including Emmeline Ventures and Disrupt Health Impact Fund, as well as existing investors Esplanade Ventures and Portfolia. -   -   Nearly 10 million Americans  have osteoporosis, a...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353314">https://www.webwire.com/ViewPressRel.asp?aId=353314</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/42381/353314/353314-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353314</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>UK start-ups to power a new wave of quantum innovation</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353381</link>
     <pubDate>Wed, 15 Apr 2026 11:02:24 EDT</pubDate>
     <description><![CDATA[<p> The start-ups have joined the DeepTech Catalyst Quantum incubator programme (DTC Quantum), where they will use quantum technologies to develop and commercialise new products designed to deliver practical, real-world benefits. -   -  DTC Quantum is led by the Science and Technology Facilities Council (STFC) in collaboration with the UK Research and Innovation (UKRI) National Quantum Computing Centre (NQCC) at the Harwell Science and Innovation Campus, Oxfordshire. -   -  The programme supports star...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353381">https://www.webwire.com/ViewPressRel.asp?aId=353381</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/7/353381/353381-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353381</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>FDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353367</link>
     <pubDate>Wed, 15 Apr 2026 10:11:56 EDT</pubDate>
     <description><![CDATA[<p> The U.S. Food and Drug Administration issued a draft guidance for sponsors seeking approval of human gene therapy products involving genome editing technologies. When finalized, this guidance will provide recommendations for standardized methods for comprehensively assessing the safety of genome editing therapies to bring effective treatments to patients sooner. -   -  &#8220;Genome editing holds extraordinary promise for treating previously incurable genetic diseases, and today&#39;s announcement repre...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353367">https://www.webwire.com/ViewPressRel.asp?aId=353367</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/353367/353367-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353367</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>AMA launches &#8220;Health vs. Hype&#8221; podcast series with iHeartMedia</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353363</link>
     <pubDate>Wed, 15 Apr 2026 10:05:05 EDT</pubDate>
     <description><![CDATA[<p> The American Medical Association (AMA), in collaboration with iHeartMedia&#39;s Ruby studio, today announced the launch of its new podcast series, &#8220;Health vs. Hype with the AMA.&#8221; The eight-episode series will provide an entertaining deep dive into the latest viral wellness trends, DIY medicine, and common health myths. Each episode will also include an evidence-based discussion with a physician to help listeners understand the trend and distinguish between which health claims are real, which a...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353363">https://www.webwire.com/ViewPressRel.asp?aId=353363</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/353363/353363-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353363</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Osteoboost and Midi Health to Host Free Webinar on HRT and Bone Density for Women in Menopause</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353310</link>
     <pubDate>Tue, 14 Apr 2026 12:03:23 EDT</pubDate>
     <description><![CDATA[<p>  Osteoboost Health, Inc.  and  Midi Health  will co-host a free public webinar,  HRT and the New Science of Strong Bones,  on Thursday, April 16, 2026, at 2 p.m. PT (5 p.m. ET). Hosted by Osteoboost CEO Laura Yecies and moderated by Osteoboost Chief Medical Officer Dr. Pamela Peeke, the one-hour live event will feature Midi Health Chief Clinical Officer Dr. Mindy Goldman in a fireside chat on the latest science behind how hormone replacement therapy (HRT) affects bone density during perime...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353310">https://www.webwire.com/ViewPressRel.asp?aId=353310</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/42381/353310/353310-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353310</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Sanofi and Regeneron&#39;s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353244</link>
     <pubDate>Mon, 13 Apr 2026 20:27:56 EDT</pubDate>
     <description><![CDATA[<p> The European Commission has approved Dupixent (dupilumab) for the treatment of moderate-to-severe chronic spontaneous urticaria (CSU) in children aged two to 11 years with inadequate response to histamine-1 antihistamines (H1AH) and who are na�ve to anti-immunoglobulin E (IgE) therapy for CSU. This expands the previous  approval  in the EU for adults and adolescents aged 12 years and older with CSU, a chronic, inflammatory skin disease that causes sudden and debilitating hives and recurrin...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353244">https://www.webwire.com/ViewPressRel.asp?aId=353244</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/8/353244/353244-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353244</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>The Brain&#39;s Emotional Hub Is Linked to Alcohol Use Differently in Young Men and Women</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353218</link>
     <pubDate>Mon, 13 Apr 2026 12:39:16 EDT</pubDate>
     <description><![CDATA[<p> New research shows that the threat-response in the brain&#39;s amygdala (which processes emotions) is linked to different patterns of drinking by sex. In young males, heightened amygdala reactivity was linked to increased depressive symptoms, which in turn predicted heavier alcohol consumption. In young females, no such pathway existed. Instead, greater amygdala reactivity was associated with lower levels of problematic drinking. The findings from the  study  in   Biological Psychiatry, publi...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353218">https://www.webwire.com/ViewPressRel.asp?aId=353218</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/353218/353218-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353218</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Ardian signs an agreement to acquire a stake in IVB Wellness Lab, a fast&amp;#8209;growing and innovative supplements brand in Spain</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=353188</link>
     <pubDate>Mon, 13 Apr 2026 04:24:41 EDT</pubDate>
     <description><![CDATA[<p> IVB Wellness Lab (&#8220;IVB&#8221;), a leading Spanish company in the research, development and distribution of science&amp;#8209;backed dietary supplements, welcomes Ardian, a global private investment firm, as a minority shareholder. -   -  Founded in 2021 by Dr. Isabel Vi�a Bas, Valerio Soto Ferri, and Carlos Vi�a Bas, IVB has established itself as one of Spain&#39;s most dynamic dietary supplement brands operating in a market driven by sustainable consumer trends around lifestyle and healthcare. Headquartere...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=353188">https://www.webwire.com/ViewPressRel.asp?aId=353188</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/7/353188/353188-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID353188</guid>
     <dc:type>Article</dc:type>
  </item>

  </channel>
</rss>
